Health-related quality of life and its risk factors in Chinese hereditary angioedema patients
暂无分享,去创建一个
Qun Xu | Y. Zhi | Shuang Liu | Yingyang Xu | Xue Wang
[1] P. Keith,et al. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. , 2018, The journal of allergy and clinical immunology. In practice.
[2] A. Maetzel,et al. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies , 2018, Orphanet Journal of Rare Diseases.
[3] R. Lockey,et al. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update , 2018, Allergy.
[4] C. Wahlgren,et al. Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden. , 2017, Allergy and asthma proceedings.
[5] N. Prior,et al. Burden of Illness and Quality-of-Life Measures in Angioedema Conditions. , 2017, Immunology and allergy clinics of North America.
[6] D. Supina,et al. Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase. , 2017, Allergy and asthma proceedings.
[7] Elaine Harniman,et al. Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36 , 2017, Allergy, Asthma & Clinical Immunology.
[8] W. Aberer,et al. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[9] P. Martus,et al. The Angioedema Quality of Life Questionnaire (AE‐QoL) – assessment of sensitivity to change and minimal clinically important difference , 2016, Allergy. European Journal of Allergy and Clinical Immunology.
[10] Juan José Yepes-Nuñez,et al. Angioedema hereditario en Medellín, Colombia: evaluación clínica y de la calidad de vida , 2015 .
[11] M. Maurer,et al. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies , 2015, Health and Quality of Life Outcomes.
[12] K. Andersen,et al. Health-related quality of life in Danish patients with hereditary angioedema. , 2015, Acta dermato-venereologica.
[13] J. Yepes-Nuñez,et al. [Hereditary angioedema in Medellín (Colombia): Clinical evaluation and quality of life appraisal]. , 2015, Biomedica : revista del Instituto Nacional de Salud.
[14] P. Keith,et al. Canadian hereditary angioedema guideline , 2014, Allergy, Asthma & Clinical Immunology.
[15] Hong-Yu Zhang,et al. Upper airway edema in 43 patients with hereditary angioedema. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[16] B. Zuraw,et al. Current update on cellular and molecular mechanisms of hereditary angioedema. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[17] A. Sheffer,et al. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency , 2014, BMC Gastroenterology.
[18] Erika F. H. Saunders,et al. Depression and anxiety in patients with hereditary angioedema. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[19] L. Mallbris,et al. Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden. , 2014, Allergy and asthma proceedings.
[20] P. Williams,et al. A UK national audit of hereditary and acquired angioedema , 2014, Clinical and experimental immunology.
[21] K. Beusterien,et al. The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. , 2014, Allergy and asthma proceedings.
[22] A. Gompel,et al. Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[23] Hong-Yu Zhang,et al. Clinical features of hereditary angioedema in Chinese patients: new findings and differences from other populations. , 2013, European journal of dermatology : EJD.
[24] R. Campos,et al. Hereditary angioedema: quality of life in Brazilian patients , 2013, Clinics.
[25] Xiu-qiang Ma,et al. Health-related quality of life in Chinese people: A population-based survey of five cities in China , 2011, Scandinavian journal of public health.
[26] C. Fagerberg,et al. Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency , 2011, Allergy.
[27] W. Lumry,et al. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. , 2010, Allergy and asthma proceedings.
[28] K. Andersen,et al. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. , 2009, European journal of dermatology : EJD.
[29] K. Bork,et al. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[30] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[31] M. Greaves,et al. The extent and nature of disability in different urticarial conditions , 1999, The British journal of dermatology.